VOR - Vor Biopharma Inc. Common Stock -  [ ]

Ticker Details
Vor Biopharma Inc. Common Stock
IPO Date: February 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $1.07B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.46 | 5.30%
Avg Daily Range (30 D): $0.60 | 3.88%
Avg Daily Range (90 D): $0.63 | 4.08%
Institutional Daily Volume
Avg Daily Volume: .23M
Avg Daily Volume (30 D): 1.12M
Avg Daily Volume (90 D): .99M
Trade Size
Avg Trade Size (Sh.): 51
Avg Trade Size (Sh.) (30 D): 81
Avg Trade Size (Sh.) (90 D): 84
Institutional Trades
Total Institutional Trades: 258
Avg Institutional Trade: $2.31M
Avg Institutional Trade (30 D): $3.36M
Avg Institutional Trade (90 D): $2.42M
Avg Institutional Trade Volume: .1M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.23M
Avg Closing Trade (30 D): $4.87M
Avg Closing Trade (90 D): $2.81M
Avg Closing Volume: 139.01K
 
News
Jul 2, 2026 @ 9:30 PM
Vor Bio Reports Inducement Grant Under Nasdaq List...
Source: Na
Jun 1, 2026 @ 9:00 PM
Vor Bio Reports Inducement Grant Under Nasdaq List...
Source: Na
Apr 1, 2026 @ 9:00 PM
Vor Bio Reports Inducement Grant Under Nasdaq List...
Source: Na
Nov 11, 2025 @ 2:56 AM
Vor Bio Announces Pricing of Public Offering of $1...
Source: Vor Biopharma Inc.
Nov 8, 2025 @ 4:45 PM
Telitacicept Achieved Primary Endpoint of Reducing...
Source: Vor Bio
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $168.31 $-5.11 $307.61
Diluted EPS $168.31 $-5.11 $307.61
Revenue $M $M $M
Gross Profit
Net Income / Loss $-883.08M $-219.59M $1.72B
Operating Income / Loss $-373.51M $-35.16M $-35.96M
Cost of Revenue
Net Cash Flow $117.58M $-226.61M $236.02M
PE Ratio    
Splits
Sep 19, 2025 1:20